Follow These Trends To Achieve The Best Results In Antidiuretic Drugs Market.
The global
antidiuretic drugs market is expected to grow at a CAGR of 9.67% during the
forecast period. Some of the prominent vendors in the global antidiuretic drugs
market include Avadel,
CSL Limited, Ferring B.V., Novartis AG, and Sanofi
among others. As per the latest market research report published by
Technavio, the global antidiuretic
drugs market size will grow by USD 68.34 million during 2019-2023. Get
the free sample report below for the detailed information.
Vendors in the market are focusing on new product
launches to increase their market reach. For instance, Avadel,
in May 2018, the company announced the
launch of NOCTIVA (desmopressin acetate). It is the first and only FDA-approved
treatment proven to help adults with nocturia due to nocturnal polyuria.
CSL Limited,
in May 2018, the company announced
that the US FDA had approved a 3,500 IU (international unit) vial size for
IDELVION for treating hemophilia B.
Ferring B.V., in
July 2018, the company announced that the US FDA had approved ZOMACTON
(somatropin) for injection in four additional pediatric indications.
Novartis AG, in
August 2018, the company received the European Commission approval for KYMRIAH
for the treatment of pediatric and young adult patients up to 25 years of age
with B-cell acute lymphoblastic leukemia. Hence, the
increasing number of product launches by vendors is expected to drive the
growth of the global antidiuretic drugs market during the forecast period. To know the complete and in-depth analysis and
forecast of this market get the complete report by clicking the link below.
Get the Complete Report @ http://bit.ly/36SjbTt
Comments
Post a Comment